|
2025
|
Invention
|
Compounds.
Compounds of general formula (1):
Compounds of general formula (1):
Compounds... |
|
2023
|
Invention
|
Benzimidazole derivatives for treating respiratory disease.
Compounds of general formula (I): (I... |
|
2022
|
Invention
|
Compounds. 2, Z and Y are as defined herein are positive modulators of the calcium-activated chlo... |
|
|
Invention
|
Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide. ... |
|
|
Invention
|
Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions.
C... |
|
|
Invention
|
Pyridine derivatives as calcium-activated chloride channel modulators. 3 are as defined herein ar... |
|
2021
|
Invention
|
Benzimidazole derivatives for treating respiratory disease. Compounds of general formula (I): (I)... |
|
|
Invention
|
Compounds for treating respiratory disease. Compounds of general formula (I) and their tautomeric... |
|
|
Invention
|
Modulators of tmem16a for treating respiratory disease. Compounds of general formula (I):
2 and ... |
|
2020
|
Invention
|
Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions. Co... |
|
|
Invention
|
Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phneyl)acetyl]amino]pyridine-2-carboxamide. ... |
|
|
Invention
|
Modulators of tmem16a for treating respiratory disease. Compounds of general formula (I), which a... |
|
2019
|
Invention
|
Tmem16a modulators. Compounds of general formula (I): wherein R1, R2, R3, R4, R5a, R5b X1, X2, Z ... |
